
Daniel E. Kolker
Supervisory Patent Examiner (ID: 15434, Phone: (571)272-3181 , Office: P/1644 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1645, 1644, 1646, 1649 |
| Total Applications | 545 |
| Issued Applications | 176 |
| Pending Applications | 78 |
| Abandoned Applications | 291 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15615805
[patent_doc_number] => 20200078307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => POROUS SILICA PARTICLES FOR USE IN A COMPRESSED PHARMACEUTICAL DOSAGE FORM
[patent_app_type] => utility
[patent_app_number] => 16/613764
[patent_app_country] => US
[patent_app_date] => 2019-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13193
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16613764
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/613764 | POROUS SILICA PARTICLES FOR USE IN A COMPRESSED PHARMACEUTICAL DOSAGE FORM | Mar 10, 2019 | Abandoned |
Array
(
[id] => 20479282
[patent_doc_number] => 12527745
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-20
[patent_title] => Pharmaceutical dosage form for an emulsion of simethicone and loperamide
[patent_app_type] => utility
[patent_app_number] => 16/975911
[patent_app_country] => US
[patent_app_date] => 2019-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1260
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16975911
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/975911 | Pharmaceutical dosage form for an emulsion of simethicone and loperamide | Feb 25, 2019 | Issued |
Array
(
[id] => 14465449
[patent_doc_number] => 20190184364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => FRAGRANCE COMPOSITIONS CONTAINING MICROCAPSULES
[patent_app_type] => utility
[patent_app_number] => 16/284605
[patent_app_country] => US
[patent_app_date] => 2019-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16284605
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/284605 | FRAGRANCE COMPOSITIONS CONTAINING MICROCAPSULES | Feb 24, 2019 | Abandoned |
Array
(
[id] => 16144005
[patent_doc_number] => 10705070
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-07-07
[patent_title] => Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
[patent_app_type] => utility
[patent_app_number] => 16/277265
[patent_app_country] => US
[patent_app_date] => 2019-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 38
[patent_no_of_words] => 166023
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16277265
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/277265 | Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug | Feb 14, 2019 | Issued |
Array
(
[id] => 16540972
[patent_doc_number] => 20200407385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => Process for Preparation of Bis-Choline Tetrathiomolybdate
[patent_app_type] => utility
[patent_app_number] => 16/970379
[patent_app_country] => US
[patent_app_date] => 2019-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8601
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970379
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/970379 | Process for preparation of bis-choline tetrathiomolybdate | Feb 14, 2019 | Issued |
Array
(
[id] => 16482304
[patent_doc_number] => 20200375904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => METHOD FOR MANUFACTURING DRUG-CONTAINING PARTICLES
[patent_app_type] => utility
[patent_app_number] => 16/970150
[patent_app_country] => US
[patent_app_date] => 2019-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970150
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/970150 | METHOD FOR MANUFACTURING DRUG-CONTAINING PARTICLES | Feb 14, 2019 | Abandoned |
Array
(
[id] => 16236640
[patent_doc_number] => 20200253874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => WOUND SEALING POWDER
[patent_app_type] => utility
[patent_app_number] => 16/274406
[patent_app_country] => US
[patent_app_date] => 2019-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5438
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16274406
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/274406 | Wound sealing powder | Feb 12, 2019 | Issued |
Array
(
[id] => 16523664
[patent_doc_number] => 20200397744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => COMPOSITIONS COMPRISING CO-CRYSTALS OF STILBENOIDS AND CANNABINOIDS
[patent_app_type] => utility
[patent_app_number] => 16/968428
[patent_app_country] => US
[patent_app_date] => 2019-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4728
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968428
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968428 | COMPOSITIONS COMPRISING CO-CRYSTALS OF STILBENOIDS AND CANNABINOIDS | Feb 7, 2019 | Abandoned |
Array
(
[id] => 16435542
[patent_doc_number] => 20200352867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => PHARMACEUTICAL FORMULATION FOR A SOLID DOSAGE FORM OF OPIOID RECEPTOR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/966645
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966645
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/966645 | PHARMACEUTICAL FORMULATION FOR A SOLID DOSAGE FORM OF OPIOID RECEPTOR ANTAGONISTS | Jan 31, 2019 | Abandoned |
Array
(
[id] => 16710266
[patent_doc_number] => 20210077413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => CHOLESTYRAMINE FORMULATIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/965297
[patent_app_country] => US
[patent_app_date] => 2019-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25466
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16965297
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/965297 | CHOLESTYRAMINE FORMULATIONS AND METHODS OF USE | Jan 29, 2019 | Abandoned |
Array
(
[id] => 18634857
[patent_doc_number] => 11759428
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Pharmaceutical formulation comprising esomeprazole and sodium bicarbonate
[patent_app_type] => utility
[patent_app_number] => 16/965726
[patent_app_country] => US
[patent_app_date] => 2019-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2813
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16965726
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/965726 | Pharmaceutical formulation comprising esomeprazole and sodium bicarbonate | Jan 27, 2019 | Issued |
Array
(
[id] => 15239779
[patent_doc_number] => 20190374675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => IMPLANTABLE MEDICAL DEVICES COMPRISING BIO-DEGRADABLE ALLOYS WITH ENHANCED DEGRADATION RATES
[patent_app_type] => utility
[patent_app_number] => 16/255093
[patent_app_country] => US
[patent_app_date] => 2019-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16255093
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/255093 | Implantable medical devices comprising bio-degradable alloys with enhanced degradation rates | Jan 22, 2019 | Issued |
Array
(
[id] => 15264887
[patent_doc_number] => 20190381177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => Liquid Pentablock Co-Polymer Formulations for Sustained Delivery of Therapeutics
[patent_app_type] => utility
[patent_app_number] => 16/248874
[patent_app_country] => US
[patent_app_date] => 2019-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16248874
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/248874 | Liquid Pentablock Co-Polymer Formulations for Sustained Delivery of Therapeutics | Jan 15, 2019 | Abandoned |
Array
(
[id] => 17586532
[patent_doc_number] => 11324774
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-10
[patent_title] => Compositions of oral alkaline salts and metabolic acid inducers and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/237885
[patent_app_country] => US
[patent_app_date] => 2019-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 89
[patent_no_of_words] => 20624
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16237885
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/237885 | Compositions of oral alkaline salts and metabolic acid inducers and uses thereof | Jan 1, 2019 | Issued |
Array
(
[id] => 16504646
[patent_doc_number] => 20200383902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => PERIODONTAL DISEASE THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/959614
[patent_app_country] => US
[patent_app_date] => 2018-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959614
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959614 | Periodontal disease therapy | Dec 30, 2018 | Issued |
Array
(
[id] => 16671440
[patent_doc_number] => 20210060203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => TISSUE ADHERENT CHITOSAN MATERIAL THAT RESISTS DISSOLUTION
[patent_app_type] => utility
[patent_app_number] => 16/958311
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28682
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -70
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16958311
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/958311 | TISSUE ADHERENT CHITOSAN MATERIAL THAT RESISTS DISSOLUTION | Dec 27, 2018 | Pending |
Array
(
[id] => 15708453
[patent_doc_number] => 20200100992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => OIL-IN-WATER EMULSION FOR MAKING UP AND CARING FOR THE LIPS
[patent_app_type] => utility
[patent_app_number] => 16/618054
[patent_app_country] => US
[patent_app_date] => 2018-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5543
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16618054
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/618054 | Oil-in-water emulsion for making up and caring for the lips | Dec 16, 2018 | Issued |
Array
(
[id] => 16052919
[patent_doc_number] => 20200188314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => GEL FORMULATION FOR TREATING DIABETIC FOOT ULCER INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/221540
[patent_app_country] => US
[patent_app_date] => 2018-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6019
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16221540
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/221540 | Gel formulation for treating diabetic foot ulcer infections | Dec 15, 2018 | Issued |
Array
(
[id] => 14226965
[patent_doc_number] => 20190125655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => MOLECULARLY IMPRINTED POLYMERS OF SOL-GEL TYPE AND THEIR USE AS ANTIDANDRUFF AGENT
[patent_app_type] => utility
[patent_app_number] => 16/208709
[patent_app_country] => US
[patent_app_date] => 2018-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5197
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16208709
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/208709 | MOLECULARLY IMPRINTED POLYMERS OF SOL-GEL TYPE AND THEIR USE AS ANTIDANDRUFF AGENT | Dec 3, 2018 | Abandoned |
Array
(
[id] => 15145181
[patent_doc_number] => 20190351068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => COMPOSITIONS AND METHODS FOR DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/204739
[patent_app_country] => US
[patent_app_date] => 2018-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18249
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16204739
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/204739 | COMPOSITIONS AND METHODS FOR DRUG DELIVERY | Nov 28, 2018 | Abandoned |